title: Treatment of fetal goitrous hypothyroidism: value of direct intramuscular L-thyroxine therapy.
authors.forename: Edgardo
authors.initials: E
authors.lastname: Corral
authors.forename: Mauricio
authors.initials: M
authors.lastname: Reascos
authors.forename: Yudith
authors.initials: Y
authors.lastname: Preiss
authors.forename: Shanna M
authors.initials: SM
authors.lastname: Rompel
authors.forename: Waldo
authors.initials: W
authors.lastname: Sepulveda
mesh_terms: D000328:Adult; D013956:Antithyroid Agents / Q000009:adverse effects; D017218:Cordocentesis; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006042:Goiter / Q000188:drug therapy*; D006111:Graves Disease / Q000150:complications / Q000188:drug therapy; D020249:Hormone Replacement Therapy; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced / Q000188:drug therapy*; D007273:Injections, Intramuscular; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011441:Propylthiouracil / Q000009:adverse effects; D013974:Thyroxine / Q000008:administration & dosage*; D014463:Ultrasonography
chemical_list: D013956:Antithyroid Agents; D011441:Propylthiouracil; D013974:Thyroxine